ENGN
enGene TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ENGN vs peer average
77/100
ENGN vs. peer average (B vs. D)
Grade spread
A 1 · B 2 · C 1 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CGON is the first available peer comparator.
Closest public clinical-stage comparator in high-risk BCG-unresponsive NMIBC with CIS; useful for judging the efficacy/durability bar investors apply to detalimogene.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ENGN
enGene Therapeutics
CGON
CG Oncology
Grade
B
C
Momentum
46
45
Value
58
41
Sentiment
79
64
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs CGON
ENGN / CGON
Grade Position
Above peers
ENGN vs. peer average (B vs. D)
77/100
Momentum
46
ENGNValue
58
ENGNSentiment
79
ENGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ENGN
CGON is the first peer returned for this comparison set.